Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, MiRNA-based Regenerative therapy for DM: MiRNA-425 increases insulin-secreting cell mass and function via up regulation of its target genes, 6/February/2015, 09.10 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that MiRNA-425, by decreasing the expression of its target gene, it may increase insulin-secreting cell mass and function. Thereby, it may increase the insulin sensitivity of cellular tissues. Thus, pharmacological formulations encompassing “MiRNA-425 or its activators” can be used to treat DM.
Amount: $ 500*
Undisclosed information: How MiRNA-425 increases insulin-secreting cell mass and function.
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation